Navigation Links
Dmitry Medvedev Presented BIOCAD the First National "Industry" Award
Date:7/10/2014

evelopment, Russian pharmaceutical companies are creating a powerful technologic basis for the production of innovative products and are competing successfully on the global pharmaceutical market. Of course, our foreign colleagues are not happy with this. However, now we can deliver innovative medicines that have no analogues in the world. The project MabNext is a bright example of this," said Dmitriy Morozov, CEO of BIOCAD.

The main advantage of products based on monoclonal antibodies, is that they affect only selected cells or molecules, in other words, these are targeted therapies.  Only relevant targets are neutralized without affecting the healthy cells.

BIOCAD has more than 10 of such innovative products based on monoclonal antibodies at different stages of development. One of the most noticeable ones is an antibody specific for interleukin 17. Clinical trials of this drug will begin in 2014. The drug has no analogues on the market and its characteristics are superior to anti-IL17 antibodies being developed by foreign companies. This product has huge potential when it comes to the treatment of socially significant diseases such as rheumatoid arthritis and psoriasis.

If we talk about cancer - the company is at the stage of developing original products based on monoclonal antibodies against targets such as PD-1, HER3, Ang-2 and others. Antibodies for PD-1 increase ability of patient's immune system to recognize and destroy tumor cells.


'/>"/>
SOURCE BIOCAD
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. A New Mechanism for Tau Protein Pathology in Alzheimers Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting
2. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
3. Startling results in synthetic chemistry presented in Nature Chemistry
4. Data From Phase II Trial of Prolor Biotechs Long-acting Human Growth Hormone Presented at Endo 2012
5. New Boehringer Ingelheim Oncology Data to be Presented at ESMO 2012 Congress
6. Top Contenders For the First Annual 2012 Fright Night Awards Presented By Cancer Bites Announced
7. Promising Data Presented on GenVec Malaria Program
8. Amgen Highlights Data To Be Presented At American Society of Hematology Annual Meeting
9. Phase II Data Presented at ACNP 2012 Shows Novel Antidepressant GLYX-13 Significantly Reduces Depression Scores Within Hours
10. Data Presented at American Society of Hematology from Ibrutinib Phase 1b/2 and Phase 2 Trials Suggest High and Durable Response in Chronic Lymphocytic Leukemia
11. Data on the Selexis SUREtechnology Platform to be Presented at PEPTALK 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... September 30, 2014 Follow us ... of each type of cholesterol carrier or lipoprotein in ... of excessive cholesterol levels in the body, especially along ... to heart attack and other cardiovascular disorders. Cardiovascular Diseases ... testing for cholesterol levels on a regular basis, to ...
(Date:9/30/2014)... 2014 CORD:USE Cord Blood Bank – ... has entered into an Equity and Exclusive Services Agreement ... series of patented technologies for the isolation of human ... Tianhe is performing Phase I/II clinical trials in ... using Tianhe,s Stem Cell Educator Therapy showing that ...
(Date:9/30/2014)... Switzerland (PRWEB) September 30, 2014 ... software solutions for drug discovery and related ... FUNGITECT consortium has chosen Genedata Selector as ... sequencing (NGS) data. FUNGITECT is a European ... invasive fungal diseases via individualized anti-fungal drug ...
(Date:9/30/2014)... Sept. 30, 2014  KemPharm, Inc., a clinical-stage ... development of proprietary new molecular entity (NME) prodrugs, ... Trademark Office (USPTO) issued U.S. Patent No. 8,816,083 ... Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid ... Use Thereof." The patent, which extends ...
Breaking Biology Technology:Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 2Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 3Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 4CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 2CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 3CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 4FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2
... products coming soon to Bioniche,s growing line of injectable ... ... Bioniche Pharma, a leading,developer and manufacturer of injectable pharmaceuticals, announced today,the acquisition ... chloride injection, USP) 10 mg/mL, 15 mL vial -- ENLON-PLUS(R) (edrophonium ...
... Moore named as Vice President, Marketing and Sales; Susan Koppy ... named as Vice President, Corporate Development, PT. ... appointment of Terrence Moore to the position of,Vice President, Marketing ... Corporate Development. Both Mr. Moore and Ms. Koppy will report,to ...
... based on cells manufactured from bone ... round, SALT LAKE CITY and HAMBURG, Germany, July ... of innovative cell therapies,for the treatment of acute kidney ... financing. The round was led by SV Life Sciences ...
Cached Biology Technology:Bioniche Pharma Acquires Baxter's ENLON(R) and ENLON-PLUS(R) 2Transcept Pharmaceuticals Appoints Key Senior Executives 2Transcept Pharmaceuticals Appoints Key Senior Executives 3Transcept Pharmaceuticals Appoints Key Senior Executives 4AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 3
(Date:9/30/2014)... new research, involving mice and published in the October ... Biology , suggests that just because you can ... a team of Italian scientists have found that using ... the immune system. This damage may result in autoimmune ... inflammatory bowel disease and rheumatoid arthritis in adulthood. , ...
(Date:9/30/2014)... Mass. , Sept. 30, 2014 /PRNewswire/ ... control solutions for the biotech and power ... its new RECONN Bioprocess Manager, an easy-to-use ... solution geared towards bioprocess development laboratories. ... have disparate bioreactor and analyzer systems. Accessing ...
(Date:9/29/2014)... A new study confirms that the exposure to tar ... than of regular cigarettes. Similarly, exposure to nicotine ... increasingly popular type of cigarette in several countries around ... of certain toxic chemicals in the smoke of these ... because lower levels of chemicals in the smoke are ...
Breaking Biology News(10 mins):Adolescent exposure to thc may cause immune systems to go up in smoke 2Spectra Automation Introduces RECONN Bioprocess Manager 2Slim cigarette smokers not exposed to more harmful chemicals 2
... differences account for some of the most of the spectacular ... plumage of peacocks, tusks on walruses and antlers on moose. ... mating is thought to be a particularly potent force ... females. However, the genetic processes responsible for producing such ...
... PAUL (05/03/2012) Vegetation, such as a patch of prairie or ... when more plant species are present, a new University of ... found that each species plays a role in maintaining a ... The study found that every additional species in a plot ...
... of California, Berkeley, scientists are drilling into ancient sediments ... clues that could help them better predict how today,s ... increasing population. The lake sediments are among the ... as far as 500,000 years. The core drilling ...
Cached Biology News:Biologists turn back the clock to understand evolution of sex differences 2Plant diversity is key to maintaining productive vegetation, U of M study shows 2Scientists core into California's Clear Lake to explore past climate change 2Scientists core into California's Clear Lake to explore past climate change 3Scientists core into California's Clear Lake to explore past climate change 4
RAT ANTI MOUSE METALLOPHILIC MACROPHAGES...
S. O'Hare & C.K. Atterwill • In vitro toxicity techniques for regular lab use. Ex vivo techniques are also covered with the aim of reducing and refining the use of animals in the future....
Form: Ready to use Applications: ELISA...
Form: Ready to use Applications: ELISA...
Biology Products: